original ) (raw )How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension
Elisa Roca
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017
View PDFchevron_right
HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs
Nail Caglar
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2015
View PDFchevron_right
Use of Calcium Channel Blockers in Cardiovascular Risk Reduction
Julio Acosta
American Journal Cardiovascular Drugs, 2010
View PDFchevron_right
Calcium channel blockers and hypertension
Allegra Battistoni
Journal of cardiovascular pharmacology and therapeutics, 2015
View PDFchevron_right
Efficacy and Safety of Dual Calcium Channel Blockade for the Treatment of Hypertension: A Meta-Analysis
A. Benjo
2013
View PDFchevron_right
The role of calcium channel blockers in the treatment of hypertension
Luigi Cubeddu
American Heart Journal, 1986
View PDFchevron_right
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT
Luis Miguel
Lancet, 2000
View PDFchevron_right
Management of Hypertension- Insights Into Real-World Clinical Practice for Differential Usage of Calcium Channel Blockers (CCBS)
Arup Dasbiswas
Journal of Evidence Based Medicine and Healthcare
View PDFchevron_right
Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects
Gianpaolo Reboldi
American journal of hypertension, 2004
View PDFchevron_right
Efficacy and safety of ACT-280778, a dual L- and T-type calcium channel blocker, in patients with mild-to-moderate essential hypertension: results from a phase 2a, randomized, double-blind, placebo- and active-controlled trial (REDUCE–1)
Jasper Dingemanse
View PDFchevron_right
Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension
Jasper Dingemanse
Journal of human hypertension, 2015
View PDFchevron_right
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients
Caterina Marciano
Journal of Hypertension, 2009
View PDFchevron_right
Difference in the Occurrence of Cardiovascular Events According to Class of Antihypertensive Agent, Based on a Follow-Up Study of Japanese Hypertension Patients
Hideaki Toyoshima
Japanese Heart Journal, 2001
View PDFchevron_right
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Jackson Wright
Hypertension, 2006
View PDFchevron_right
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
José Cangiano
JAMA, 2003
View PDFchevron_right
Antihypertensive drugs: Issues beyond blood pressure control
Jonathan Pinkney
Progress in Cardiovascular Diseases, 1994
View PDFchevron_right
Spectrum of antihypertensive therapy in South Asians at a tertiary care hospital in Pakistan
Aamir Khan
BMC Research Notes, 2011
View PDFchevron_right
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Joe Blanton
2003
View PDFchevron_right
Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
Hirofumi Maruyama
Journal of atherosclerosis and thrombosis, 2017
View PDFchevron_right
Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients: The CA-ATTEND study
Hirofumi Maruyama
Clinical and experimental hypertension (New York, N.Y. : 1993), 2017
View PDFchevron_right
Calcium antagonists: Not appropriate as first line antihypertensive agents
Curt Furberg
1996
View PDFchevron_right
Antihypertensive effects of a new dihydropyridine calcium antagonist
Ali nekooeian
Arzneimittel-Forschung, 1986
View PDFchevron_right
Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study
Dhruvi Pandit
American journal of cardiovascular disease, 2021
View PDFchevron_right
Current Treatment of Patients with Hypertension
Stefano Taddei
Drugs, 2003
View PDFchevron_right
Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups
Khoo Ee Ming
Singapore Medical Journal, 2009
View PDFchevron_right
Calcium channel blockers: the present and the future
John Pieper
Pharmacotherapy
View PDFchevron_right
Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension
Joseph Diamond
American journal of hypertension, 2001
View PDFchevron_right
Management of Hypertension in the Asia-Pacific Region: A Structured Review
Huynh Van Minh
American journal of cardiovascular drugs, 2024
View PDFchevron_right
Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case–Control Studies on Italian Hypertensive Elderly
Alfredo Vannacci , Niccolò Lombardi
View PDFchevron_right
Comparisons of Increasing Calcium Channel Blocker dose and Adding Thiazide Diuretic in Hypertensive Patients Given Medium-dose Angiotensin II Receptor Blocker and Amlodipine
Akihiro Tojo
Dokkyo journal of medical sciences, 2017
View PDFchevron_right